Condition: Morbid Obesity · Sponsor: IHU Strasbourg
Endoscopic sleeve gastroplasty (ESG) is a technique used for bariatric surgery, with results comparable to conventional surgery, in order to treat morbid obesity. It has also less risks of complications, and it is not an irreversible technique. It can be repeated overtime, regarding the evolution of the gastroplasty. There is little data in the literature on the effectiveness of endoscopic "revision". This study will assess the benefits and costs of a revision during the follow-up endoscopy.
This description comes directly from the study's public registry record.
Pierre GOEPFERT · 0390413646 · pierre.goepfert@ihu-strasbourg.eu
Armelle TAKEDA · 0390413608 · armelle.takeda@ihu-strasbourg.eu
Always discuss trial participation with your own doctor first.
| Service de chirurgie digestive et endocrinienne, NHC | Strasbourg, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04945473